Salarius Pharmaceuticals (SLRX) Q4 2025 Earnings

14NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-33.6
-23
-12.41
-1.81

Details

Expected EPS
-33.6
Actual EPS
-1.81
Surprise EPS
31.79
Surprise Percent
+94.61%

Description

Salarius Pharmaceuticals (SLRX) has reported earnings of -1.81 per share for Q4 2025.

0 Comments

Share your thoughts